Cargando…
Tumor progression locus 2 ablation suppressed hepatocellular carcinoma development by inhibiting hepatic inflammation and steatosis in mice
BACKGROUND: Tumor progression locus 2 (TPL2), a serine-threonine kinase, functions as a critical regulator of inflammatory pathways and mediates oncogenic events. The potential role of Tpl2 in nonalcoholic fatty liver disease (NAFLD) associated hepatocellular carcinoma (HCC) development remains unkn...
Autores principales: | Li, Xinli, Liu, Chun, Ip, Blanche C., Hu, Kang-Quan, Smith, Donald E., Greenberg, Andrew S., Wang, Xiang-Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642781/ https://www.ncbi.nlm.nih.gov/pubmed/26560698 http://dx.doi.org/10.1186/s13046-015-0254-2 |
Ejemplares similares
-
Isocaloric Pair-Fed High-Carbohydrate Diet Induced More Hepatic Steatosis and Inflammation than High-Fat Diet Mediated by miR-34a/SIRT1 Axis in Mice
por: Li, Xinli, et al.
Publicado: (2015) -
Hepatocellular Carcinoma in a Patient With Hepatic Steatosis
por: Romano, John, et al.
Publicado: (2020) -
NIK links inflammation to hepatic steatosis by suppressing PPARα in alcoholic liver disease
por: Li, Yaru, et al.
Publicado: (2020) -
miRNA-132 induces hepatic steatosis and hyperlipidaemia by synergistic multitarget suppression
por: Hanin, Geula, et al.
Publicado: (2018) -
Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma: Implications for Lycopene Intervention
por: Ip, Blanche C., et al.
Publicado: (2013)